What does ERP validation mean in pharma?
ERP validation in pharma is documented assurance that GxP-relevant ERP functions are fit for intended use and remain controlled through change. The objective is not to validate SAP, Oracle, or Dynamics as a generic product. The regulated company must identify the processes, data, configuration, interfaces, roles, reports, and custom components that can affect regulated operations or records.
For system-specific planning, see the SAP ERP validation guide, the CSV workflow, and the VLMS guide.
Define GxP Scope Before You Define Tests
Start with intended use and process impact. Do not place an entire ERP platform in scope simply because it supports a regulated company. Validate the functions and data that influence regulated decisions or records, and document why other areas are excluded.
| ERP Area | Typical Position | Why It Matters |
|---|---|---|
| Batch / material status | Often In Scope | Can affect manufacturing, quarantine, release, or disposition |
| Quality workflows | Often In Scope | May support deviations, CAPA, inspection, or quality decisions |
| GxP master data | Depends | Relevant when data drives production, quality, traceability, or status controls |
| Finance / payroll | Typically Out | Usually outside GxP scope unless it directly supports a regulated decision or record |
Use GAMP 5 Categories at Component Level
ERP landscapes usually combine configured functions, integrations, standard services, and custom code. GAMP 5 Second Edition category is one input to lifecycle planning, not a shortcut for deciding validation scope or test depth. Credible supplier evidence can support assurance of standard functionality; custom ABAP, extensions, scripts, or bespoke integrations normally need more company-specific evidence.
IQ, OQ, and PQ for ERP
Control the ERP After Go-Live
The validated state can drift after release. Vendor updates, production configuration changes, new sites or products, role changes, and interface modifications should enter formal change control. Assess the GxP impact, affected requirements, data or interfaces, regression needs, and required updates to validation evidence.
For cloud ERP: include vendor release notices, release notes, testing windows, supplier evidence, and access to a suitable non-production environment so impact assessment can occur before regulated use is affected.
Apply Risk-Based Assurance Carefully
FDA's February 2026 CSA guidance formally applies to medical-device production and quality-management-system software under 21 CFR Part 820; it is not a universal pharma ERP rule. Where applicable, its risk-based approach can help focus assurance on higher process risk. Pharma and biotech ERP programmes can apply proportionate practices through GAMP 5 and their applicable GxP requirements.
- Keep current: intended use and scope, approved configuration, requirements and risks, test evidence, deviations, interfaces, access controls, critical master-data governance, change assessments, and periodic review decisions.
Where GoVal Fits
GoVal provides a controlled workspace for ERP requirements, risk assessments, test evidence, traceability, deviations, approvals, change impact, and periodic review. The same validation record used at go-live remains available as the ERP configuration, integrations, and supplier releases change.
Related Topics
Frequently Asked Questions
What GAMP 5 category is an ERP system? +
Which ERP functions need validation in pharma? +
How should ERP vendor updates be handled? +
Does FDA CSA apply to every pharma ERP? +
Keep ERP validation evidence connected through change
Manage requirements, risk, testing, traceability, deviations, change impact, and periodic review in GoVal.